x hide permanently

Venaxis acquires Boulder biotech

Denver Business Journal

Venaxis Inc., a Castle Rock medical device company, said it's acquired BiOptix Diagnostics Inc. of Boulder. Venaxis (Nasdaq: APPY) said in a Securities and Exchange Commission filing that it's paying "627,010 shares of Venaxis common stock with an aggregate value of $1,950,000" for BiOptix. BiOptix uses technology developed by Dr. John 'Jan' Hall, a professor at the University of Colorado, who shared the Nobel Prize for Physics in 2005...